Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors.
Naomi Gerzvolf MieresPrograma de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Paraná, Curitiba 80210-170, Brazil.ORCID 0009-0009-6426-6186
Soraia de Oliveira SimiãoPrograma de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Paraná, Curitiba 80210-170, Brazil.ORCID 0009-0004-7008-805X
Luiza Stolz CruzDepartamento de Farmácia, Universidade Estadual do Centro-Oeste, Guarapuava 85040-167, Brazil.
Rafaela Cirillo de MeloPrograma de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Paraná, Curitiba 80210-170, Brazil.
Najeh Maissar KhalilApplied Nanostructured Systems Laboratory, Universidade Estadual do Centro-Oeste, Guarapuava 85040-167, Brazil.
Juliana Sartori BoniniDepartamento de Farmácia, Universidade Estadual do Centro-Oeste, Guarapuava 85040-167, Brazil.ORCID 0000-0001-5144-2253
Fabiane Gomes de Moraes RegoPrograma de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Paraná, Curitiba 80210-170, Brazil.ORCID 0000-0003-1726-8524
Marcel Henrique Marcondes SariPrograma de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Paraná, Curitiba 80210-170, Brazil.ORCID 0000-0002-9913-9306
Roberto PontaroloPrograma de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Paraná, Curitiba 80210-170, Brazil.ORCID 0000-0002-7049-4363
Raul Edison Luna LazoPrograma de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Paraná, Curitiba 80210-170, Brazil.ORCID 0000-0002-3434-1239
Jéssica Brandão ReolonDepartamento de Farmácia, Universidade Estadual do Centro-Oeste, Guarapuava 85040-167, Brazil.ORCID 0000-0001-7388-8256
Luana Mota FerreiraPrograma de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Paraná, Curitiba 80210-170, Brazil.ORCID 0000-0001-9951-587X
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
cutaneous cancer therapydrug repurposingpolymeric nanoparticlestopical drug delivery
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Bioadhesive Eudragit RL · full record | OpenQuestion